Vanta Bioscience forays into Clinical Research

30 Jul 2018 Evaluate

Vanta Bioscience has forayed into Clinical Research through a 100% subsidiary. The clinical research business will begin contributing to the top-line in the last quarter of the current financial year.

The company is projecting to add revenue of Rs 250 crore in the fifth year through clinical research services. Major activities covered under the clinical services include bio-equivalence studies in healthy human volunteers, patient volunteers, bioanalytical services and clinical trials from Phase I to Phase IV.

Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.

Vanta Bioscience Share Price

50.33 1.35 (2.76%)
28-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 915.70
Sagility India 34.94
AGS Transact Tech 79.93
Just Dial 1119.55
Krystal Integrated 769.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.